Health monitoring system, method and device

Abstract

Disclosed in the present application are a health monitoring system, method and device. A control device 11 establishes bidirectional authenticated connections with both a first health monitoring device 12 and a first drug infusion apparatus 13, and activates the first health monitoring device 12 and the first drug infusion apparatus 13; the control device 11 sends to the first drug infusion apparatus 13 first identification information of the first health monitoring device 12; on the basis of the first identification information, the first drug infusion apparatus 13 establishes a connection with the first health monitoring device 12; the first health monitoring device 12 acquires target health monitoring data of a first user, and sends the target health monitoring data to the first drug infusion apparatus 13; and the first drug infusion apparatus 13 sends the target health monitoring data to the control device 11, and infuses a drug to the first user on the basis of drug infusion indicators sent by the control device 11. The intelligence and convenience of health monitoring systems are improved. In addition, the problem of the reliability of health monitoring being relatively poor caused when a patient cannot use a control device 11 is prevented.

Description

[0001] The application relates to the technical field of health monitoring, in particular to a health monitoring system, method and device. Background art In today's world, more and more patients with chronic diseases need to take or inject drugs for a long time to relieve the disease. In the market of chronic disease treatment, health monitoring devices and drug infusion devices have a certain popularity. The health monitoring device is used to obtain health monitoring data, and the drug infusion device is used to infuse drugs into the human body. The health monitoring device can be an analyte monitoring device, such as a blood glucose monitoring device, an analyte sensor, a glucose detection sensor, a general examination monitoring device and the like. The general examination monitoring device can be a height and weight instrument, a sphygmomanometer, a blood glucose meter, a blood oxygen meter and the like. The first drug infusion device can be an infusion delivery device, such as a POD (POD). In the prior art, the health monitoring device and the drug infusion device are used as independent devices, and each is matched with a corresponding matching terminal. The health monitoring terminal is used to control the health monitoring device to perform corresponding functions, and display the health monitoring data transmitted by the health monitoring device. The drug infusion terminal is used to control the drug infusion device to infuse drugs into the human body. When the patient uses the health monitoring terminal to find that the health monitoring data of the patient is abnormal, the drug infusion terminal is controlled to infuse drugs. The prior art has the problem that the patient needs to control multiple terminals, for example, the health monitoring terminal is controlled to realize health monitoring, and the drug infusion terminal is manually controlled to realize drug infusion, and the overall health monitoring system has poor intelligence and convenience.The application provides a health monitoring system, method and device to solve the problem of poor intelligence and convenience of existing health monitoring solutions. In a first aspect, the application provides a health monitoring system, which comprises a control device, a first health monitoring device and a first drug infusion device. The control device is used to be connected with the first health monitoring device and the first drug infusion device for bidirectional authentication, and to activate the first health monitoring device and the first drug infusion device. The first health monitoring device is used to broadcast a first data packet, and carries its first identification information in the first data packet. The control device is used to receive the first data packet, obtain the first identification information carried therein, and send the first identification information to the first drug infusion device. The first drug infusion device is used to scan connectable health monitoring devices, match the first health monitoring device according to the first identification information, and establish a connection with the first health monitoring device. The first health monitoring device is used to obtain target health monitoring data of a first user, and send the target health monitoring data to the first drug infusion device. The first drug infusion device is used to send the target health monitoring data to the control device, receive drug infusion indicators corresponding to the target health monitoring data sent by the control device, and infuse drugs into the first user according to the drug infusion indicators. The application refers to a user wearing the first health monitoring device as the first user, and health monitoring data of the first user obtained by the first health monitoring device as the target health monitoring data. In a second aspect, the application provides a health monitoring method applied to a first drug infusion device, which comprises the following steps: the first drug infusion device scans connectable health monitoring devices, matches the first health monitoring device according to first identification information of the first health monitoring device, and establishes a connection with the first health monitoring device. The first identification information is obtained by the control device receiving a first data packet broadcast by the first health monitoring device, obtaining the first identification information carried therein and sending the first identification information to the first drug infusion device. The first health monitoring device sends target health monitoring data of a first user to the first drug infusion device, the first drug infusion device sends the target health monitoring data to the control device, receives drug infusion indicators corresponding to the target health monitoring data sent by the control device, and infuses drugs into the first user according to the drug infusion indicators.In a third aspect, the present application provides a health monitoring method, which is applied to a first health monitoring device, and the method comprises the following steps: the first health monitoring device broadcasts a first data packet, and carries first identification information of the first health monitoring device in the first data packet; a control device receives the first data packet, obtains the first identification information carried in the first data packet, and sends the first identification information to a first drug infusion device; the first drug infusion device scans connectable health monitoring devices, matches the first health monitoring device according to the first identification information, establishes a connection with the first health monitoring device, obtains target health monitoring data of a first user, and sends the target health monitoring data to the first drug infusion device; the first drug infusion device sends the target health monitoring data to the control device, receives drug infusion indexes corresponding to the target health monitoring data sent by the control device, and infuses drugs into the first user according to the drug infusion indexes. In a fourth aspect, the present application provides a health monitoring method, which is applied to a control device, and the method comprises the following steps: the control device is connected with the first health monitoring device and the first drug infusion device in a bidirectional authentication mode, and activates the first health monitoring device and the first drug infusion device; the control device receives a first data packet broadcast by the first health monitoring device, obtains first identification information carried in the first data packet, and sends the first identification information to the first drug infusion device; the first drug infusion device scans connectable health monitoring devices, matches the first health monitoring device according to the first identification information, and establishes a connection with the first health monitoring device; the control device receives target health monitoring data of a first user sent by the first drug infusion device, wherein the target health monitoring data is sent by the first health monitoring device to the first drug infusion device; the control device determines drug infusion indexes corresponding to the target health monitoring data, and sends the drug infusion indexes to the first drug infusion device, so that the first drug infusion device infuses drugs into the first user according to the drug infusion indexes.In a fifth aspect, the application provides a health monitoring device applied to a first drug infusion device, the device comprising: a scanning unit configured to scan a connectable health monitoring device, match to the first health monitoring device according to first identification information of the first health monitoring device, and establish a connection with the first health monitoring device; wherein the first identification information is obtained by a control device receiving a first data packet broadcast by the first health monitoring device, and sending the first identification information carried in the first data packet to the first drug infusion device; and an infusion drug unit configured to receive target health monitoring data of a first user sent by the first health monitoring device, send the target health monitoring data to the control device, receive a drug infusion index corresponding to the target health monitoring data sent by the control device, and infuse a drug into the first user according to the drug infusion index. In a sixth aspect, the application provides a health monitoring device applied to a first health monitoring device, the device comprising: a broadcasting unit configured to broadcast a first data packet, and carry first identification information of the first health monitoring device in the first data packet; a control device configured to receive the first data packet, obtain the first identification information carried in the first data packet, and send the first identification information to a first drug infusion device; the first drug infusion device is configured to scan a connectable health monitoring device, match to the first health monitoring device according to the first identification information, and establish a connection with the first health monitoring device; and an obtaining unit configured to obtain target health monitoring data of a first user, and send the target health monitoring data to the first drug infusion device; the first drug infusion device is configured to send the target health monitoring data to the control device, receive a drug infusion index corresponding to the target health monitoring data sent by the control device, and infuse a drug into the first user according to the drug infusion index.In a seventh aspect, the application provides a health monitoring device applied to a control device, the device comprising: an activation unit configured to be connected to the first health monitoring device and the first drug infusion device for bidirectional authentication respectively, and to activate the first health monitoring device and the first drug infusion device; a first receiving unit configured to receive a first data packet broadcast by the first health monitoring device, to obtain first identification information carried in the first data packet, and to send the first identification information to the first drug infusion device; the first drug infusion device is configured to scan connectable health monitoring devices, to match the first health monitoring device according to the first identification information, and to establish a connection with the first health monitoring device; a second receiving unit configured to receive target health monitoring data of a first user sent by the first drug infusion device, wherein the target health monitoring data is sent by the first health monitoring device to the first drug infusion device; and a sending unit configured to determine a drug infusion index corresponding to the target health monitoring data, and to send the drug infusion index to the first drug infusion device, so that the first drug infusion device infuses drugs to the first user according to the drug infusion index. In an eighth aspect, the application provides a drug infusion device comprising a processor, a communication interface, a memory and a communication bus, wherein the processor, the communication interface and the memory are in communication with each other through the communication bus; the memory is configured to store a computer program; and the processor is configured to execute the program stored in the memory to implement the method steps. In a ninth aspect, the application provides a health monitoring device comprising a processor, a communication interface, a memory and a communication bus, wherein the processor, the communication interface and the memory are in communication with each other through the communication bus; the memory is configured to store a computer program; and the processor is configured to execute the program stored in the memory to implement the method steps. In a tenth aspect, the application provides a control device comprising a processor, a communication interface, a memory and a communication bus, wherein the processor, the communication interface and the memory are in communication with each other through the communication bus; the memory is configured to store a computer program; and the processor is configured to execute the program stored in the memory to implement the method steps. In an eleventh aspect, the application provides a computer readable storage medium, wherein the computer readable storage medium stores a computer program, and the computer program is executed by a processor to implement the method steps.The technical scheme has the following advantages or beneficial effects: In the present application, the health monitoring system comprises a control device, a first health monitoring device and a first drug infusion device, the control device is connected with the first health monitoring device and the first drug infusion device in bidirectional authentication, and activates the first health monitoring device and the first drug infusion device, the control device obtains first identification information of the first health monitoring device according to a first data packet broadcasted by the first health monitoring device, and sends the first identification information to the first drug infusion device; the first drug infusion device establishes connection with the first health monitoring device according to the first identification information. The control device determines corresponding drug infusion indexes according to target health monitoring data of a first user obtained by the first health monitoring device, and controls the first drug infusion device to infuse drugs to the first user according to the drug infusion indexes. Compared with the scheme in which the patient uses multiple handheld terminals to realize health monitoring and manually controls the drug infusion, the present application improves the intelligence and convenience of the health monitoring system, and avoids the problem of poor health monitoring reliability when the patient cannot use the control device. DESCRIPTION OF DRAWINGS In order to more clearly illustrate the technical scheme in the embodiments of the present application, the drawings needed in the embodiment description will be briefly introduced as follows. Obviously, the drawings in the following description are only some embodiments of the present application, and other drawings can be obtained by those skilled in the art without creative effort. FIG. 1 is a structure schematic diagram of a health monitoring system provided by the present application; FIG. 2 is a structure schematic diagram of a health monitoring system provided by the present application; FIG. 3 is a structure schematic diagram of a health monitoring system provided by the present application; FIG. 4 is a structure schematic diagram of a health monitoring system provided by the present application; FIG. 5 is a health monitoring process schematic diagram provided by the present application; FIG. 6 is a health monitoring process schematic diagram provided by the present application; FIG. 7 is a health monitoring process schematic diagram provided by the present application; FIG. 8 is a structure schematic diagram of a health monitoring device provided by the present application; FIG. 9 is a structure schematic diagram of a health monitoring device provided by the present application; FIG. 10 is a structure schematic diagram of a health monitoring device provided by the present application; FIG. 11 is a flowchart of first activation and use of a drug infusion device, a health monitoring device provided by the present application; FIG. 12 is a flowchart of replacement of a health monitoring device provided by the present application; FIG. 13 is a flowchart of replacement of a drug infusion device provided by the present application; FIG. 14 is a flowchart of reconnection of a control device provided by the present application; FIG. 15 is a structure schematic diagram of a first drug infusion device provided by the present application; FIG. 16 is a structure schematic diagram of a first health monitoring device provided by the present application; FIG. 17 is a structure schematic diagram of a control device provided by the present application.In order to make the purposes and embodiments of the present application clearer, the following will clearly and completely describe the exemplary embodiments of the present application with reference to the accompanying drawings of the exemplary embodiments. Obviously, the described exemplary embodiments are only a part of the embodiments of the present application, but not all embodiments of the present application. It should be explained that the brief description of the terms in the present application is only for the convenience of understanding the following described embodiments, but is not intended to limit the embodiments of the present application. Unless otherwise stated, these terms should be understood according to their ordinary and general meanings. and the like are used interchangeably unless otherwise indicated. The terms "including" and "comprising" as well as their conjugates, are used synonymously with the term "containing" unless otherwise indicated. The term "module" refers to any known or later developed hardware, software, firmware, artificial intelligence, fuzzy logic, or combination of hardware and / or software that is capable of performing the functionality associated with that element. Finally, it should be noted that the use of particular brand names in implementation of the present application is for illustrative purposes only and is not meant to imply any preference or requirement for those particular brands; nor is it meant to exclude other brands that are well known to those of ordinary skill in the art. Furthermore, it should be understood that the various embodiments of the present application can be implemented in a variety of ways, and that the implementation described herein is only one implementation with which the present application can be practiced. Accordingly, the present application is not intended to be limited to the implementation described herein but rather is intended to be accorded a breadth of interpretation consistent with the scope of the claims.Fig. 1 is a schematic diagram of a health monitoring system provided by the present application, the system comprising: a control device 11, a first health monitoring device 12 and a first drug infusion device 13; the control device 11 is configured to be connected to the first health monitoring device 12 and the first drug infusion device 13 in a bidirectional authentication manner, and to activate the first health monitoring device 12 and the first drug infusion device 13; the first health monitoring device 12 is configured to broadcast a first data packet, and the first data packet carries first identification information of the first health monitoring device 12; the control device 11 is configured to receive the first data packet, obtain the first identification information carried in the first data packet, and send the first identification information to the first drug infusion device 13; the first drug infusion device 13 is configured to scan connectable health monitoring devices, match the first health monitoring device 12 according to the first identification information, and establish a connection with the first health monitoring device 12; the first health monitoring device 12 is configured to obtain target health monitoring data of a first user, and send the target health monitoring data to the first drug infusion device 13; and the first drug infusion device 13 is configured to send the target health monitoring data to the control device 11, receive drug infusion indicators corresponding to the target health monitoring data sent by the control device 11, and infuse drugs to the first user according to the drug infusion indicators. In the present application, the control device 11 can be a mobile terminal device such as a mobile phone, a tablet computer, a PDA (Personal Digital Assistant), and the like, and can also be a stand-alone physical server 14, a cloud server 140 of a cloud database, cloud storage or other basic cloud computing services. The control device 11 and the first drug infusion device 13 can be connected in a wired or wireless manner. The control device 11 is configured to be connected to the first health monitoring device 12 and the first drug infusion device 13 in a bidirectional authentication manner, and to activate the first health monitoring device 12 and the first drug infusion device 13. The control device 11 can activate the first health monitoring device 12 and the first drug infusion device 13 through NFC (Near Field Communication) technology. The first health monitoring device 12 broadcasts a first data packet, and the first data packet carries first identification information of the first health monitoring device 12. The first identification information can be MAC address (Media Access Control Address) information, device serial number information, name information, model information, etc. of the first health monitoring device 12.The control device 11 receives the first data packet, obtains the first identification information carried therein, and sends the first identification information to the first drug infusion device 13. The first drug infusion device 13 scans the connectable health monitoring device, matches the first health monitoring device 12 according to the first identification information, and establishes a connection with the first health monitoring device 12. The first health monitoring device 12 obtains the target health monitoring data of the first user, sends the target health monitoring data to the first drug infusion device 13, the first drug infusion device 13 forwards the target health monitoring data to the control device 11, the control device 11 determines the corresponding drug infusion index according to the target health monitoring data, wherein the drug infusion index includes drug infusion rate, drug infusion amount, etc. The control device 11 sends the drug infusion index to the first drug infusion device 13, and the first drug infusion device 13 infuses drugs to the first user according to the drug infusion index. Wherein, the first health monitoring device 12 and the first drug infusion device 13 can be wirelessly connected, for example, through Bluetooth to establish a connection. The function of the first health monitoring device 12 is to obtain the target health monitoring data of the first user, and send the target health monitoring data to the first drug infusion device 13. For example, taking the first health monitoring device 12 as a blood glucose monitoring device, the target health monitoring data of the first user can be blood glucose level data (mmol / L). The first health monitoring device 12 sends the obtained blood glucose level data (mmol / L) of the first user to the first drug infusion device 13. The first drug infusion device 13 can be various infusion devices suitable for drug infusion, for example, an insulin infusion pump (POD). The function of the first drug infusion device 13 is to receive the target health monitoring data sent by the first health monitoring device 12, and forward the target health monitoring data to the control device 11. The function of the control device 11 is to determine the corresponding drug infusion index according to the target health monitoring data, and send the drug infusion index to the first drug infusion device 13. The first drug infusion device 13 infuses drugs to the first user according to the drug infusion index. It should be noted that when the target health monitoring data received by the control device 11 changes, the corresponding drug infusion index determined is also adjusted in response. The devices and systems in the health monitoring application scenario are described below. The health monitoring system can include a continuous glucose monitoring system (CGM, Continuous Glucose Monitoring), a POD, and a terminal device. The continuous glucose monitoring system is used for continuous dynamic detection of blood glucose changes; including a blood glucose monitoring device and a PDA (Personal Digital Assistant, handheld personal digital assistant).The blood glucose monitoring device can include a glucose detection sensor, an electronic component (mainly including an antenna circuit, a battery, etc.), and a needle helper, wherein the glucose detection sensor can be inserted into the human skin surface by the needle helper to sense the glucose level; the electronic component is connected with the sensor, and can transmit the signal sensed by the sensor to the PDA for displaying the blood glucose change, or to the drug infusion device. The needle helper is used for inserting the sensor into the body fluid under the human skin surface to detect the user's analyte level. The drug infusion device can be an insulin infusion pump for infusing insulin, which pumps the liquid medicine (e.g., insulin) into the patient's body through a hollow needle (e.g., a soft needle). The needle is inserted into the subcutaneous tissue for insulin transmission. The closed-loop system composed of the dynamic blood glucose monitoring system, the drug infusion device, and the PDA can realize automatic monitoring of the blood glucose level and automatic infusion of insulin, thereby providing a convenient, safe, and fast physical health monitoring method for diabetic patients. In the present application, the health monitoring system includes a control device 11, a first health monitoring device 12, and a first drug infusion device 13, the control device 11 is connected with the first health monitoring device 12 and the first drug infusion device 13 in a bidirectional authentication manner, the control device 11 activates the first health monitoring device 12 and the first drug infusion device 13, the control device 11 obtains first identification information of the first health monitoring device 12 according to a first data packet broadcasted by the first health monitoring device 12, and sends the first identification information to the first drug infusion device 13; the first drug infusion device 13 establishes a connection with the first health monitoring device 12 according to the first identification information. The control device 11 determines a corresponding drug infusion index according to target health monitoring data of a first user obtained by the first health monitoring device 12, and controls the first drug infusion device 13 to infuse drugs to the first user according to the drug infusion index. Compared with the scheme in which the patient uses multiple handheld terminals to realize health monitoring and manually controls the drug infusion, the intelligence and convenience of the health monitoring system are improved. The present application discloses a health monitoring system, method, and device, the control device 11 is connected with the first health monitoring device 12 and the first drug infusion device 13 in a bidirectional authentication manner, activates the first health monitoring device 12 and the first drug infusion device 13, the control device 11 generates a group of random numbers as authentication information, and sends the authentication information to the first health monitoring device 12 and the first drug infusion device 13 in an encrypted manner. The control device 11 sends first identification information of the first health monitoring device 12 to the first drug infusion device 13; the first drug infusion device 13 is connected with the first health monitoring device 12 in a bidirectional authentication manner according to the first identification information and the authentication information, and realizes safe transmission of user monitoring data.The application also discloses an intelligent cooperation capability among a control device 11, a health monitoring device and a drug infusion device, including an interaction process among device moving away, replacement and the like. Compared with a scheme in which a patient uses multiple handheld terminals to realize health monitoring and realizes drug infusion in a manual control manner, the application improves the intelligence and convenience of the health monitoring system, and avoids the problem of poor health monitoring reliability caused by the fact that the patient cannot use the control device 11. In the application, the first health monitoring device 12 is used to acquire target health monitoring data of a first user, encrypt the target health monitoring data through a first shared key and then send the encrypted target health monitoring data to the first drug infusion device 13; the first drug infusion device 13 is used to decrypt the target health monitoring data by using the first shared key, encrypt the decrypted data by using a second shared key, send the data encrypted by using the second shared key to the control device 11, decrypt the data by using the second shared key after the control device 11 receives the data, and obtain the target health monitoring data; the first drug infusion device 13 receives the drug infusion index corresponding to the target health monitoring data and encrypted by using a third shared key which is sent by the control device 11, decrypts the data by using the third shared key, obtains the drug infusion index, and infuses drug into the first user according to the drug infusion index. After the first health monitoring device 12 acquires the target health monitoring data of the first user, the target health monitoring data is encrypted by using the first shared key, and then the encrypted target health monitoring data is sent to the first drug infusion device 13. The first drug infusion device 13 decrypts the received data by using the first shared key, acquires the target health monitoring data, encrypts the acquired target health monitoring data by using the second shared key, sends the encrypted target health monitoring data to the control device 11, the control device 11 decrypts the received data by using the second shared key, and obtains the target health monitoring data. The control device 11 uses the drug infusion index corresponding to the target health monitoring data, encrypts the drug infusion index by using the third shared key, and sends the encrypted drug infusion index to the first drug infusion device 13. The first drug infusion device 13 decrypts the data by using the third shared key, obtains the drug infusion index, and infuses drug into the first user according to the drug infusion index.Fig. 2 is a schematic diagram of a health monitoring system provided by the present application, the system further comprising: a server 14, the control device 11 being connected with the server 14; the control device 11 is configured to wake up the first drug infusion device 13 through near field communication technology NFC; the first drug infusion device 13 is configured to broadcast a second data packet, and the second data packet carries second identification information of the first drug infusion device 13; the second identification information can be MAC address (Media Access Control Address, physical address) information, device serial number information, name information, model information, etc. of the first drug infusion device 13; the control device 11 is configured to receive the second data packet, acquire the second identification information carried in the second data packet, and send the second identification information to the server 14 for verification; the server 14 verifies the second identification information by judging whether the server 14 is connected with the first drug infusion device 13 according to the second identification information, if yes, the verification is passed, and if no, the verification is failed; the server 14 is configured to return first authentication information to the control device 11 after the verification is passed; the control device 11 is configured to connect with the first drug infusion device 13 and perform bidirectional authentication using the first authentication information, generate a fourth shared key after the authentication is successful, and activate the first drug infusion device 13; the first drug infusion device 13 is configured to generate the fourth shared key and return an activation success notification; the process of the control device 11 connecting with the first drug infusion device 13 and performing bidirectional authentication using the first authentication information is described as follows.The control device 11 generates a first public key and a first private key according to a preset key agreement algorithm; selects an arbitrary first key from a key set contained in first authentication information, and generates first signature information by using a hash algorithm according to the selected first key, first time information and the first public key; sends a first authentication request to the first drug infusion device 13, the first authentication request carrying identification information of the first key, the first time information, the first public key and the first signature information, the first drug infusion device 13 generating second signature information by using the hash algorithm according to a key corresponding to the identification of the first key, the first time information and the first public key, to verify whether the second signature information is consistent with the first signature information; the control device 11 receives a second authentication request sent by the first drug infusion device 13 when it is determined that the second signature information is consistent with the first signature information, the second authentication request carrying identification information of a second key, second time information, a second public key and third signature information, the third signature information being generated by the first drug infusion device 13 by using the hash algorithm according to the selected second key, the second time information and the second public key, the second public key being generated by the first drug infusion device 13 according to the preset key agreement algorithm; generates fourth signature information by using the hash algorithm according to a key corresponding to the identification of the second key, the second time information and the second public key; if it is determined that the fourth signature information is consistent with the third signature information, it is determined that the authentication is successful. The control device 11 and the first drug infusion device 13 generate a fourth shared key after two-way authentication is successful, and activate the first drug infusion device 13; the first drug infusion device 13 generates the fourth shared key and returns an activation success notification. Subsequent data interaction between the control device 11 and the first drug infusion device 13 is encrypted and decrypted by the fourth shared key, thereby ensuring the security of the data. It should be noted that the data sent by the first drug infusion device 13 to the control device 11 can be encrypted by the fourth shared key, and the control device 11 decrypts the received encrypted data using the fourth shared key. The data sent by the control device 11 to the first drug infusion device 13 can also be encrypted by the fourth shared key, and the first drug infusion device 13 decrypts the received encrypted data using the fourth shared key. The first drug infusion device 13 and the control device 11 can also use different shared keys to encrypt the data sent.In the application, the control device 11 is used to wake up the first health monitoring device 12 through NFC; the first health monitoring device 12 is used to broadcast a third data packet, and the first identification information of the first health monitoring device 12 is carried in the third data packet; the control device 11 is used to receive the third data packet, obtain the first identification information carried in the third data packet, and send the first identification information to the server 14 for verification; the process of verifying the first identification information by the server 14 is to determine whether the server 14 is connected with the first health monitoring device 12 according to the first identification information, if yes, the verification is passed, and if not, the verification is not passed; the server 14 is used to return second authentication information to the control device 11 after the verification is passed; the control device 11 is used to connect with the first health monitoring device 12 and perform two-way authentication by using the second authentication information, generate a fifth shared key after the authentication is successful, and activate the first health monitoring device 12; the first health monitoring device 12 is used to generate the fifth shared key and return an activation success notification. The process of two-way authentication of the control device 11 and the first health monitoring device 12 by using the second authentication information is as follows. The control device 11 generates a public key and a private key according to a preset key negotiation algorithm; an arbitrary key is selected from a key set contained in the second authentication information, and signature information is generated by using a hash algorithm according to the selected key, time information and the public key; an authentication request is sent to the first health monitoring device 12, and the authentication request carries the identification information of the key, the time information, the public key and the signature information; the first health monitoring device 12 generates signature information by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key, so as to verify whether the two signature information are consistent; the control device 11 receives the authentication request sent by the first health monitoring device 12 when it is determined that the two signature information are consistent, and the authentication request carries the identification information of the key, the time information, the public key and the signature information; the signature information is generated by the first health monitoring device 12 by using the hash algorithm according to the selected key, the time information and the public key; the public key is generated by the first health monitoring device 12 according to the preset key negotiation algorithm; signature information is generated by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key; if it is determined that the two signature information are consistent, it is determined that the authentication is successful. The control device 11 and the first health monitoring device 12 generate a fifth shared key after two-way authentication is successful, and activate the first health monitoring device 12; the first health monitoring device 12 generates the fifth shared key and returns an activation success notification.The data interaction between the subsequent control device 11 and the first health monitoring device 12 is encrypted and decrypted by the fifth shared key, so as to ensure the security of the data. It should be noted that the data sent by the first health monitoring device 12 to the control device 11 can be encrypted by the fifth shared key, and the control device 11 decrypts the received encrypted data using the fifth shared key. The data sent by the control device 11 to the first health monitoring device 12 can also be encrypted by the fifth shared key, and the first health monitoring device 12 decrypts the received encrypted data using the fifth shared key. It can also be that the first health monitoring device 12 and the control device 11 use different shared keys to encrypt the data sent. In this application, the control device 11 is configured to randomly generate third authentication information, encrypt the third authentication information using the fifth shared key and send the third authentication information to the first health monitoring device 12; the first health monitoring device 12 is configured to decrypt the received encrypted information using the fifth shared key and obtain the third authentication information; the control device 11 disconnects the connection with the first health monitoring device 12; the control device 11 encrypts the first identification information and the third authentication information using the fourth shared key and sends the first identification information and the third authentication information to the first drug infusion device 13; the first drug infusion device 13 is configured to decrypt the received encrypted information using the fourth shared key and obtain the third authentication information and the first identification information; the first health monitoring device 12 is configured to broadcast a fourth data packet, and the first identification information of the first health monitoring device 12 is carried in the fourth data packet; the first drug infusion device 13 is configured to scan connectable health monitoring devices, match the first health monitoring device 12 according to the first identification information, and establish a connection with the first health monitoring device 12; the first drug infusion device 13 is configured to perform bidirectional authentication with the first health monitoring device 12 using the third authentication information, generate a sixth shared key after the authentication is successful, and return first state information indicating that the binding of the first health monitoring device 12 is successful to the control device 11. The process of bidirectional authentication of the first drug infusion device 13 and the first health monitoring device 12 using the third authentication information is described as follows.The first health monitoring device 12 generates a public key and a private key according to a preset key agreement algorithm; selects an arbitrary key from a key set contained in the third authentication information, and generates signature information by using a hash algorithm according to the selected key, time information and the public key; sends an authentication request to the first drug infusion device 13, wherein the authentication request carries identification information of the key, the time information, the public key and the signature information, the first drug infusion device 13 generates signature information by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key, so as to verify whether the two signature information are consistent; the first health monitoring device 12 receives the authentication request sent by the first drug infusion device 13 when it is determined that the two signature information are consistent, wherein the authentication request carries identification information of the key, time information, a public key and signature information, the signature information is generated by the first drug infusion device 13 by using the hash algorithm according to the selected key, the time information and the public key, and the public key is generated by the first drug infusion device 13 according to the preset key agreement algorithm; signature information is generated by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key; if it is determined that the two signature information are consistent, it is determined that the authentication is successful. The first drug infusion device 13 and the first health monitoring device 12 generate a sixth shared key after two-way authentication is successful. The data interaction between the first drug infusion device 13 and the first health monitoring device 12 in the subsequent process is encrypted and decrypted by the sixth shared key, so as to ensure the security of the data. It should be noted that the data sent by the first health monitoring device 12 to the first drug infusion device 13 can be encrypted by the sixth shared key, and the first drug infusion device 13 decrypts the received encrypted data by using the sixth shared key. The data sent by the first drug infusion device 13 to the first health monitoring device 12 can also be encrypted by the sixth shared key, and the first health monitoring device 12 decrypts the received encrypted data by using the sixth shared key. The first health monitoring device 12 and the first drug infusion device 13 can also use different shared keys to encrypt the data. In this application, considering that the first health monitoring device 12 has a validity period, the validity period is generally one day, two days, etc. When the validity period of the first health monitoring device 12 has passed, the first health monitoring device 12 is invalid, and is disconnected with the first drug infusion device 13. In order to replace the second health monitoring device 15 when the first health monitoring device 12 is invalid, continue to monitor the health of the first user, the system further comprises a second health monitoring device 15. Fig. 3 is a structure schematic diagram of a health monitoring system provided by the application.The first drug infusion device 13 is also used for disconnecting the first health monitoring device 12 when it is identified that the first health monitoring device 12 is out of date, and sending second state information that the first drug infusion device 13 is disconnected with the first health monitoring device 12 and third state information that the first health monitoring device 12 is out of date to the control device 11; the control device 11 is also used for receiving the second state information and the third state information, and awakening the second health monitoring device 15 through NFC; the second health monitoring device 15 is used for broadcasting a fifth data packet, and carrying the third identification information of itself in the fifth data packet; the control device 11 is used for receiving the fifth data packet, obtaining the third identification information carried in the fifth data packet, and connecting with the second health monitoring device 15 through two-way authentication and activating the second health monitoring device 15, and sending the third identification information to the first drug infusion device 13; the control device 11 is used for generating fourth authentication information randomly and sending the fourth authentication information to the second health device and the first drug infusion device 13; the first drug infusion device 13 is used for scanning the connectable health monitoring device, matching the second health monitoring device 15 according to the third identification information, and connecting with the second health monitoring device 15 through two-way authentication according to the fourth authentication information. The process that the first drug infusion device 13 connects with the second health monitoring device 15 through two-way authentication according to the fourth authentication information is described as follows.The first drug infusion device 13 generates a public key and a private key according to a preset key agreement algorithm; selects an arbitrary key from a key set contained in the fourth authentication information, and generates signature information by using a hash algorithm according to the selected key, time information and the public key; sends an authentication request to the second health monitoring device 15, the authentication request carrying identification information of the key, the time information, the public key and the signature information, the second health monitoring device 15 generating signature information by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key, to check whether the two signature information are consistent; the first drug infusion device 13 receives the authentication request sent by the second health monitoring device 15 when it is determined that the two signature information are consistent, the authentication request carrying identification information of the key, time information, a public key and signature information, the signature information being generated by the second health monitoring device 15 according to the selected key, the time information and the public key by using the hash algorithm, and the public key being generated by the second health monitoring device 15 according to the preset key agreement algorithm; generates signature information by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key; if it is determined that the two signature information are consistent, it is determined that the authentication is successful. After the first health monitoring device 12 is disabled, the connection function of the first health monitoring device 12 is abnormal, at this time, the first drug infusion device 13 connected with the first health monitoring device 12 can recognize that it is disconnected with the first health monitoring device 12. At this time, the first drug infusion device 13 sends second state information that it is disconnected with the first health monitoring device 12 and third state information that the first health monitoring device 12 is expired to the control device 11. After the control device 11 receives the second state information and the third state information, and the first user wears the second health monitoring device 15, the control device 11 wakes up the second health monitoring device 15 by NFC. After the control device 11 activates the second health monitoring device 15, the second health monitoring device 15 broadcasts a fifth data packet, which carries third identification information of the second health monitoring device 15; the third identification information can be MAC address information, device serial number information, name information, model information, etc. of the second health monitoring device 15.The control device 11 receives the fifth data packet, obtains the third identification information carried therein, and sends the third identification information to the first drug infusion device 13; the first drug infusion device 13 scans the connectable health monitoring device, matches the second health monitoring device 15 according to the third identification information, and is connected with the second health monitoring device 15 in a bidirectional authentication manner and activates the second health monitoring device 15. After the first drug infusion device 13 is connected with the second health monitoring device 15, the second health monitoring device 15 obtains the target health monitoring data of the first user, and sends the target health monitoring data to the first drug infusion device 13; the first drug infusion device 13 sends the target health monitoring data to the control device 11, receives the drug infusion index corresponding to the target health monitoring data sent by the control device 11, and infuses the drug into the first user according to the drug infusion index. In the present application, considering that the first drug infusion device 13 has an effective period, the effective period is generally one day, two days, etc. When the effective period of the first drug infusion device 13 has passed, the first drug infusion device 13 is invalid, and is disconnected with the control device 11 and the health monitoring device. In order to replace the second drug infusion device 16 when the first drug infusion device 13 is invalid, and continue to monitor the health of the first user, the system further comprises: a second drug infusion device 16. FIG. 4 is a schematic structural diagram of a health monitoring system provided by the present application. The control device 11 is further used for connecting with the third health monitoring device activated last time when it is identified that the first drug infusion device 13 is invalid due to expiration, and obtaining the health monitoring data collected by the third health monitoring device; the control device 11 is further used for, when the second drug infusion device 16 is detected, waking up, bidirectionally authenticating and activating the second drug infusion device 16 through NFC, and sending fourth identification information of the third health monitoring device to the second drug infusion device 16; the control device 11 is used for randomly generating fifth authentication information and sending the fifth authentication information to the third health monitoring device and the second drug infusion device 16 in an encrypted manner; the second drug infusion device 16 is used for scanning the connectable health monitoring device, matching the third health monitoring device according to the fourth identification information, and bidirectionally authenticating and connecting with the third health monitoring device according to the fifth authentication information. If the first drug infusion device 13 is invalid due to expiration, and the first user does not wear the second drug infusion device 16, the control device 11 is connected with the third health monitoring device activated last time.If the last activation is the first health monitoring device 12, the first health monitoring device 12 is taken as the third health monitoring device; if the last activation is the second health monitoring device 15, the second health monitoring device 15 is taken as the third health monitoring device, and the third health monitoring device sends the collected health monitoring data to the control device 11, and the control device 11 acquires the health monitoring data collected by the third health monitoring device. If the first drug infusion device 13 expires and the first user wears the second drug infusion device 16, the control device 11 wakes up, authenticates and activates the second drug infusion device 16 through NFC; the control device 11 sends the fourth identification information of the third health monitoring device to the second drug infusion device 16, the second drug infusion device 16 scans the connectable health monitoring device, matches the third health monitoring device according to the fourth identification information, and authenticates and connects with the third health monitoring device according to the fifth authentication information. The process of the second drug infusion device 16 authenticating and connecting with the third health monitoring device according to the fifth authentication information is as follows. The second drug infusion device 16 generates a public key and a private key according to a preset key negotiation algorithm; selects an arbitrary key from a key set contained in the fifth authentication information, and generates signature information by using a hash algorithm according to the selected key, time information and the public key; sends an authentication request to the third health monitoring device, wherein the authentication request carries the identification information of the key, the time information, the public key and the signature information, the third health monitoring device generates signature information by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key, to verify whether the two signature information are consistent; the second drug infusion device 16 receives the authentication request sent by the third health monitoring device when it is determined that the two signature information are consistent, wherein the authentication request carries the identification information of the key, the time information, the public key and the signature information, the signature information is generated by the third health monitoring device by using the hash algorithm according to the selected key, the time information and the public key, and the public key is generated by the third health monitoring device according to the preset key negotiation algorithm; generates signature information by using the hash algorithm according to the key corresponding to the identification of the key, the time information and the public key; if it is determined that the two signature information are consistent, it is determined that the authentication is successful. After the first drug infusion device 13 is disabled, the connection function of the first drug infusion device 13 is abnormal, and at this time the control device 11 connected with the first drug infusion device 13 can recognize that the first drug infusion device 13 is disconnected.At this time, the first user wears the second drug infusion device 16, and the control device 11 activates the second drug infusion device 16. At this time, the control device 11 can wake up and activate the second drug infusion device 16 through NFC. After the control device 11 activates the second drug infusion device 16, the second identification information of the third health monitoring device that is activated last time is obtained. The third health monitoring device that is activated last time can be the first health monitoring device 12 or the second health monitoring device 15. FIG. 4 takes the second health monitoring device 15 as an example. The fourth identification information of the third health monitoring device that is activated last time includes MAC address (Media Access Control Address, physical address) information, device serial number information, name information, model information, etc. The control device 11 sends the fourth identification information of the third health monitoring device that is activated last time to the second drug infusion device 16. The second drug infusion device 16 can search for the health monitoring device that is activated last time according to the second identification information, and establish a Bluetooth connection with the health monitoring device that is activated last time. After the second drug infusion device 16 is connected with the third health monitoring device that is activated last time, the third health monitoring device obtains the target health monitoring data of the first user, and sends the target health monitoring data to the second drug infusion device 16. The second drug infusion device 16 sends the target health monitoring data to the control device 11, receives the drug infusion index corresponding to the target health monitoring data sent by the control device 11, and infuses the drug into the first user according to the drug infusion index. Wherein, the control device 11 adjusts the drug infusion index in real time according to the pre-set drug infusion rule. In this application, the control device 11 is also used for disconnecting with the third drug infusion device in a connected state and the fourth health monitoring device when detecting that the control device 11 is away from the third drug infusion device and the fourth health monitoring device. The third drug infusion device is used for receiving the health monitoring data sent by the fourth health monitoring device after detecting that the control device 11 is disconnected, determining the drug infusion index corresponding to the health monitoring data, and infusing the drug into the first user according to the drug infusion index. The third drug infusion device in a connected state can be the first drug infusion device 13 or the second drug infusion device 16. The fourth health monitoring device in a connected state can be the first health monitoring device 12 or the second health monitoring device 15.The control device 11 has the highest priority, and the drug infusion device needs to send health monitoring data to the control device 11 in the case that the control device 11 is not disconnected, the drug infusion index is determined by the control device 11 and sent to the drug infusion device, and then the drug infusion device infuses the drug to the user according to the drug infusion index. When the control device 11 is disconnected, the drug infusion device has the ability to determine the corresponding drug infusion index according to the health monitoring data, and at this time the drug infusion device determines the drug infusion index and infuses the drug to the user according to the drug infusion index. After the third drug infusion device is disconnected with the control device 11, it is also used for broadcasting a sixth data packet, and the fifth identification information of the third drug infusion device is carried in the sixth data packet; the control device 11 is also used for scanning the connectable drug infusion device, matching to the third drug infusion device according to the fifth identification information, and establishing connection with the third drug infusion device; the third drug infusion device is used for receiving the health monitoring data sent by the fourth health monitoring device after detecting that the connection with the control device 11 is established and the bidirectional authentication is successful, sending the health monitoring data to the control device 11, receiving the drug infusion index corresponding to the health monitoring data sent by the control device 11, and infusing the drug to the first user according to the drug infusion index. FIG. 5 is a health monitoring process schematic diagram provided by the present application, which is applied to the first drug infusion device 13 and includes the following steps.

[0002] S101: The first drug infusion device 13 scans the connectable health monitoring device, matches to the first health monitoring device 12 according to the first identification information of the first health monitoring device 12, and establishes connection with the first health monitoring device 12; wherein the control device 11 receives the first data packet broadcasted by the first health monitoring device 12, obtains the first identification information carried therein and sends the first identification information to the first drug infusion device 130

[0003] S102: receiving target health monitoring data of a first user sent by the first health monitoring device 12, sending the target health monitoring data to a control device 11, receiving drug infusion indicators corresponding to the target health monitoring data sent by the control device 11, and infusing drugs into the first user according to the drug infusion indicators. Optionally, the first drug infusion device 13 receives the target health monitoring data of the first user encrypted by a first shared key sent by the first health monitoring device 12; decrypts the target health monitoring data using the first shared key, and encrypts the decrypted data using a second shared key, sends the data encrypted by the second shared key to the control device 11, the control device 11 decrypts the data using the second shared key after receiving the data, and obtains the target health monitoring data; the control device 11 sends drug infusion indicators corresponding to the target health monitoring data encrypted by a third shared key to the first drug infusion device 13, the first drug infusion device 13 decrypts the data using the third shared key, and obtains the drug infusion indicators, and infuses drugs into the first user according to the drug infusion indicators. Optionally, the first drug infusion device 13 broadcasts a second data packet, and carries its own second identification information in the second data packet; the control device 11 receives the second data packet, obtains the second identification information carried therein, sends the second identification information to the server 14 for verification, returns first authentication information to the control device 11 after verification, connects with the first drug infusion device 13 and performs bidirectional authentication using the first authentication information, generates a fourth shared key after successful authentication, and activates the first drug infusion device 13; the first drug infusion device 13 generates the fourth shared key and returns an activation success notification. Wherein, the first drug infusion device 13 decrypts the received encrypted information using the fourth shared key, obtains third authentication information and first identification information; scans connectable health monitoring devices, matches the first health monitoring device 12 according to the first identification information, establishes a connection with the first health monitoring device 12; performs bidirectional authentication with the first health monitoring device 12 using the third authentication information, generates a sixth shared key after successful authentication, and returns first state information indicating that the first health monitoring device 12 is successfully bound to the control device 11.The first drug infusion device 13 disconnects the connection with the first health monitoring device 12 when identifying that the first health monitoring device 12 is overdue, and sends second state information that the first drug infusion device 13 is disconnected with the first health monitoring device 12 and third state information that the first health monitoring device 12 is overdue to the control device 11; the control device 11 receives the second state information and the third state information, and wakes up the second health monitoring device 15 through NFC; the second health monitoring device 15 broadcasts a fifth data packet, and carries the third identification information of the second health monitoring device 15 in the fifth data packet; the control device 11 receives the fifth data packet, obtains the third identification information carried in the fifth data packet, and establishes a two-way authentication connection with the second health monitoring device 15 and activates the second health monitoring device 15, and sends the third identification information to the first drug infusion device 13; the control device 11 scans the connectable health monitoring device, matches the second health monitoring device 15 according to the third identification information, and establishes a two-way authentication connection with the second health monitoring device 15 according to the fourth authentication information. FIG. 6 is a health monitoring process provided by the application, which is applied to the first health monitoring device 12 and includes the following steps.

[0004] S201: The first health monitoring device 12 broadcasts a first data packet, and carries the first identification information of the first health monitoring device 12 in the first data packet; the control device 11 receives the first data packet, obtains the first identification information carried in the first data packet, and sends the first identification information to the first drug infusion device 13; the first drug infusion device 13 scans the connectable health monitoring device, matches the first health monitoring device 12 according to the first identification information, and establishes a connection with the first health monitoring device 12.

[0005] S202: Obtain target health monitoring data of the first user, and send the target health monitoring data to the first drug infusion device 13; the first drug infusion device 13 sends the target health monitoring data to the control device 11, receives the drug infusion index corresponding to the target health monitoring data sent by the control device 11, and infuses drug O to the first user according to the drug infusion index. Optionally, the first health monitoring device 12 obtains target health monitoring data of the first user, encrypts the target health monitoring data through a first shared key, and sends the encrypted target health monitoring data to the first drug infusion device 13; the first drug infusion device 13 decrypts the target health monitoring data using the first shared key, encrypts the decrypted data using a second shared key, and sends the data encrypted using the second shared key to the control device 11; after receiving the data, the control device 11 decrypts the data using the second shared key to obtain the target health monitoring data; the first drug infusion device 13 receives the drug infusion index corresponding to the target health monitoring data sent by the control device 11 and encrypted using a third shared key, decrypts the data using the third shared key to obtain the drug infusion index, and infuses drug to the first user according to the drug infusion index. Wherein, the first health monitoring device 12 broadcasts a third data packet, and carries the first identification information of the first health monitoring device 12 in the third data packet; the control device 11 receives the third data packet, obtains the first identification information carried in the third data packet, sends the first identification information to the server 14 for verification, returns second authentication information to the control device 11 after verification, connects with the first health monitoring device 12 and performs bidirectional authentication using the second authentication information, generates a fifth shared key after successful authentication, activates the first health monitoring device 12, and generates the fifth shared key and returns an activation success notification.The first health monitoring device 12 uses the fifth shared key to decrypt the received encrypted information to obtain the third authentication information; wherein, the third authentication information is randomly generated by the control device 11, and the third authentication information is encrypted using the fifth shared key and sent to the first health monitoring device 12; a fourth data packet is broadcast, and the first identification information of the control device 11 is carried in the fourth data packet; the control device 11 receives the fourth data packet and obtains the first identification information carried therein; the first health monitoring device 12 is scanned by the first drug infusion device 13, and the first health monitoring device 12 is matched to the first health monitoring device 12 according to the first identification information, and a connection is established with the first health monitoring device 12; the third authentication information is used for bidirectional authentication with the first health monitoring device 12, and after successful authentication, a sixth shared key is generated, and the first state information of the first health monitoring device 12 is returned to the control device 11. Figure 7 is a health monitoring process provided by the application, which is applied to the control device 11 and includes the following steps.

[0006] S301: The control device 11 is connected with the first health monitoring device 12 and the first drug infusion device 13 for bidirectional authentication, and the first health monitoring device 12 and the first drug infusion device 13 are activated.

[0007] S302: The first identification information carried in the first data packet broadcast by the first health monitoring device 12 is obtained, and the first identification information is sent to the first drug infusion device 13; the first health monitoring device 12 is matched to the first health monitoring device 12 according to the first identification information, and a connection is established with the first health monitoring device 12.

[0008] S303: The target health monitoring data of the first user sent by the first drug infusion device 13 is received, wherein the target health monitoring data is sent by the first health monitoring device 12 to the first drug infusion device 13.

[0009] S304 : determining a drug infusion indicator corresponding to the target health monitoring data, sending the drug infusion indicator to the first drug infusion device 13, and the first drug infusion device 13 infuses drug to the first user according to the drug infusion indicator. The control equipment 11 receives the data decrypted by the first drug infusion device 13 using the second shared key; wherein the target health monitoring data of the first user is obtained by the first health monitoring equipment 12, and the target health monitoring data is sent to the first drug infusion device 13 after being encrypted by the first shared key; the target health monitoring data is decrypted by the first drug infusion device 13 using the first shared key, and the data after decryption is encrypted using the second shared key; the data is decrypted using the second shared key to obtain the target health monitoring data, the drug infusion indicator corresponding to the target health monitoring data is encrypted using the third shared key and sent to the first drug infusion device 13, the data is decrypted by the first drug infusion device 13 using the third shared key to obtain the drug infusion indicator, and the drug is infused to the first user according to the drug infusion indicator. Wherein, the control equipment 11 wakes up the first drug infusion device 13 through the near field communication technology NFC; receives the second data packet broadcasted by the first drug infusion device 13, obtains the second identification information carried therein, sends the second identification information to the server 14 for verification, receives the first authentication information returned by the server 14 after verification, and connects with the first drug infusion device 13 and uses the first authentication information for bidirectional authentication, generates the fourth shared key after successful authentication, and activates the first drug infusion device 13; the first drug infusion device 13 is used for generating the fourth shared key, and returns an activation success notification. Wherein, the control equipment 11 wakes up the first health monitoring equipment 12 through NFC; receives the third data packet broadcasted by the first health monitoring equipment 12, obtains the first identification information carried therein, sends the first identification information to the server 14 for verification, receives the second authentication information returned by the server 14 after verification, and connects with the first health monitoring equipment 12 and uses the second authentication information for bidirectional authentication, generates the fifth shared key after successful authentication, and activates the first health monitoring equipment 12; the first health monitoring equipment 12 generates the fifth shared key, and returns an activation success notification.Wherein, the control device 11 generates third authentication information randomly, encrypts the third authentication information using the fifth shared key and sends to the first health monitoring device 12; the first health monitoring device 12 decrypts the received encrypted information using the fifth shared key, obtains the third authentication information; the control device 11 disconnects the connection with the first health monitoring device 12; encrypts the first identification information and the third authentication information using the fourth shared key and sends to the first drug infusion device 13; the first drug infusion device 13 decrypts the received encrypted information using the fourth shared key, obtains the third authentication information and the first identification information; the first health monitoring device 12 broadcasts a fourth data packet, carries its own first identification information in the fourth data packet; the first drug infusion device 13 scans the connectable health monitoring device, matches to the first health monitoring device 12 according to the first identification information, establishes connection with the first health monitoring device 12; uses the third authentication information for bidirectional authentication with the first health monitoring device 12, generates a sixth shared key after successful authentication, and returns the first state information of binding the first health monitoring device 12 to the control device 11 successfully. Wherein, the control device 11 receives the second state information and the third state information, wakes up the second health monitoring device 15 through NFC; Wherein, when the first drug infusion device 13 identifies that the first health monitoring device 12 expires, disconnects the connection with the first health monitoring device 12, and sends the second state information of disconnecting the connection with the first health monitoring device 12 and the third state information of the expiration of the first health monitoring device 12 to the control device 11; receives the fifth data packet broadcasted by the second health monitoring device 15, obtains the third identification information carried therein, and connects with the second health monitoring device 15 bidirectionally and activates the second health monitoring device 15, sends the third identification information to the first drug infusion device 13; generates fourth authentication information randomly and encrypts and sends to the second health device and the first drug infusion device 13; the first drug infusion device 13 scans the connectable health monitoring device, matches to the second health monitoring device 15 according to the third identification information, and connects with the second health monitoring device 15 bidirectionally according to the fourth authentication information.Wherein, the control device 11 is connected with the third health monitoring device activated last time, and acquires the health monitoring data collected by the third health monitoring device when identifying that the first drug infusion device 13 expires and invalidates and the second drug infusion device 16 is not detected; the second drug infusion device 16 is activated by NFC, two-way authentication and activation when the second drug infusion device 16 is detected; the fourth identification information of the third health monitoring device is sent to the second drug infusion device 16; the fifth authentication information is randomly generated and sent to the third health monitoring device and the second drug infusion device 16; the second drug infusion device 16 scans the connectable health monitoring device, matches the third health monitoring device according to the fourth identification information, and is connected with the third health monitoring device according to the fifth authentication information. Wherein, the control device 11 is disconnected with the third drug infusion device when detecting that the control device 11 is away from the third drug infusion device and the fourth health monitoring device in the connected state; the health monitoring data sent by the fourth health monitoring device is received by the third drug infusion device after detecting that the control device 11 is disconnected, and the drug infusion index corresponding to the health monitoring data is determined, and the drug is infused to the first user according to the drug infusion index. Wherein, the control device 11 scans the connectable drug infusion device, matches the third drug infusion device according to the fifth identification information, and establishes connection with the third drug infusion device; wherein, the sixth data packet is broadcasted by the third drug infusion device after being disconnected with the control device 11, and the fifth identification information of the third drug infusion device is carried in the sixth data packet; the health monitoring data sent by the fourth health monitoring device is received by the third drug infusion device after establishing connection with the control device 11 and two-way authentication, the health monitoring data is sent to the control device 11, the drug infusion index corresponding to the health monitoring data sent by the control device 11 is received, and the drug is infused to the first user according to the drug infusion index.Fig. 8 is a schematic diagram of a health monitoring device structure provided by the present application, the device comprising: a scanning unit 21, configured to scan connectable health monitoring equipment, match to a first health monitoring equipment 12 according to first identification information of the first health monitoring equipment 12, and establish a connection with the first health monitoring equipment 12; wherein the first identification information is that a control device 11 receives a first data packet broadcast by the first health monitoring equipment 12, obtains the first identification information carried therein, and sends the first identification information to the first drug infusion device 13 by the control device 11; and an infusion drug unit 22, configured to receive target health monitoring data of a first user sent by the first health monitoring equipment 12, send the target health monitoring data to the control device 11, receive drug infusion indicators corresponding to the target health monitoring data sent by the control device 11, and infuse drugs to the first user according to the drug infusion indicators. Fig. 9 is a schematic diagram of a health monitoring device structure provided by the present application, the device comprising: a broadcasting unit 31, configured to broadcast a first data packet, and carry first identification information of itself in the first data packet; a control device 11 receives the first data packet, obtains the first identification information carried therein, and sends the first identification information to a first drug infusion device 13; the first drug infusion device 13 scans connectable health monitoring equipment, matches to the first health monitoring equipment 12 according to the first identification information, and establishes a connection with the first health monitoring equipment 12; a obtaining unit 32, configured to obtain target health monitoring data of a first user, and send the target health monitoring data to the first drug infusion device 13; the first drug infusion device 13 sends the target health monitoring data to the control device 11, receives drug infusion indicators corresponding to the target health monitoring data sent by the control device 11, and infuses drugs to the first user according to the drug infusion indicators.Fig. 10 is a schematic diagram of a health monitoring device structure provided by the present application, the device comprising: an activation unit 41, configured to be connected to the first health monitoring device 12 and the first drug infusion device 13 in a bidirectional authentication manner respectively, and to activate the first health monitoring device 12 and the first drug infusion device 13; a first receiving unit 42, configured to receive a first data packet broadcast by the first health monitoring device 12, acquire first identification information carried in the first data packet, and send the first identification information to the first drug infusion device 13; the first drug infusion device 13 scans connectable health monitoring devices, matches the first health monitoring device 12 according to the first identification information, and establishes a connection with the first health monitoring device 12; a second receiving unit 43, configured to receive target health monitoring data of a first user sent by the first drug infusion device 13, wherein the target health monitoring data is sent by the first health monitoring device 12 to the first drug infusion device 13; and a sending unit 44, configured to determine a drug infusion index corresponding to the target health monitoring data, and send the drug infusion index to the first drug infusion device 13. The first drug infusion device 13 infuses drugs to the first user according to the drug infusion index. In the present application, the control device 11 can be connected to the drug infusion device through Bluetooth Low Energy, the drug infusion device can be connected to the health monitoring device through Bluetooth Low Energy, the control device 11 can realize control and adjustment of the drug infusion device through a guidance algorithm by acquiring health monitoring data, and the drug infusion device can maintain a connection state with the health monitoring device and make adjustment according to health monitoring data when the control device 11 loses the connection. Fig. 11 is a flowchart of a first activation and use process of a drug infusion device and a health monitoring device provided by the present application, which involves the interaction among a control device, a health monitoring device and a drug infusion device. The process comprises the following steps.

[0010] S401: A user logs in to a system through a username and a password or a mobile phone number and a verification code;

[0011] S402: A server returns a login token;

[0012] S403: The user wakes up a drug infusion device through an NFC of a control device;

[0013] S404: The drug infusion device starts to send a Bluetooth broadcast packet outward;

[0014] S405: After receiving the Bluetooth broadcast packet, the control device checks a server according to a MAC address, and judges whether to connect to the device;

[0015] S406: After the server verification is successful, it returns device authentication information C1 to the control device;

[0016] S407: The control device and the drug infusion device are connected via Bluetooth and use C1 for two-way authentication. After successful authentication, a shared key Keyl is generated and the drug infusion device is activated.

[0017] S408: The drug infusion device generates a shared key Keyl and returns an activation success notification;

[0018] S409: The user wakes up the health monitoring device using the NFC of the control device;

[0019] S410: The health monitoring device begins sending out Bluetooth broadcast packets;

[0020] S411: After receiving the Bluetooth broadcast packet, the control device verifies the MAC address with the server to determine whether it is connected to the device.

[0021] S412: Verification passed, device authentication information C2 returned;

[0022] S413: The control device and the health monitoring device connect via Bluetooth and use C2 for two-way authentication. After successful authentication, a shared key Key2 is generated and the health monitoring device is activated.

[0023] S414: The health monitoring device generates a shared key Key2 and returns an activation success notification;

[0024] S415: The control device generates a set of random authentication information C3 for subsequent authentication between the drug infusion device and the health monitoring device;

[0025] S416: The control device uses Key2 to encrypt C3 using the AES encryption algorithm and transmits it to the health monitoring device via Bluetooth;

[0026] S417: The health monitoring device successfully received the data and decrypted the received information using Key2 to obtain...

[0027] C3 Save; S418: Control device disconnects Bluetooth connection from health monitoring device;

[0028] S419: The health monitoring device has successfully disconnected via Bluetooth. At this time, the health monitoring device will continue to send out Bluetooth broadcast data packets.

[0029] S420: The control device sends the C3 and health monitoring device information (including the unique identifier of the health monitoring device and state information, etc.) to the drug infusion device after encryption by AES using Keyl;

[0030] S421: The drug infusion device receives the information successfully, decrypts the received information using Keyl, and obtains C3, which is saved;

[0031] S422: The drug infusion device scans the surrounding connectable health monitoring devices, matches the received health monitoring device information, and when a match is successful, connects to the device through Bluetooth;

[0032] S423: The health monitoring device returns a connection success notification;

[0033] S424: The drug infusion device and the health monitoring device complete mutual authentication using the authentication information C3 and generate a shared key Key3 for subsequent data transmission;

[0034] S425: The drug infusion device notifies the control device that the health monitoring device binding is successful;

[0035] S426: The control device saves the binding relationship of the control device, the drug infusion device, and the health monitoring device to the server. At this point, the control device first activates the drug infusion device and the health monitoring device, and completes the connection for use. In this process, the control device only activates the health monitoring device, and after activation, the connection is disconnected. No health monitoring data is transmitted between the control device and the health monitoring device. In the data transmission stage, the control device and the drug infusion device use Keyl as the key of the AES encryption algorithm to encrypt and transmit data. The control device and the health monitoring device use Key2 as the key of the AES encryption algorithm to encrypt and transmit data. The health monitoring device and the drug infusion device use Key3 as the key of the AES encryption algorithm to encrypt and transmit data. When any party is disconnected, re-authentication is required, and a new data transmission key is generated. FIG. 12 is a health monitoring device replacement process flow provided by the present application, including the following steps:

[0036] S501: The user normally uses the control device to connect the drug infusion device and the health monitoring device.

[0037] S502: When the drug infusion device detects that the health monitoring device is expired, the control device 11 is notified, and the Bluetooth connection with the expired health monitoring device is disconnected. S503: The control device prompts the user to wear a new health monitoring device, and after wearing, the new health monitoring device is woken up through NFC, and then the activation process and the connection process of the drug infusion device and the health monitoring device are performed. The steps of S503 are the same as the process principles of S410-S426 in FIG. 11, and will not be described in detail. At this point, the health monitoring device replacement is completed. FIG. 13 is a drug infusion device replacement flowchart provided by the present application, including the following steps:

[0038] S601: The user normally uses the control device to connect the drug infusion device and the health monitoring device.

[0039] S602: When the expired drug infusion device is expired, the control device, the expired drug infusion device, and the health monitoring device are disconnected through Bluetooth.

[0040] S603: The user does not wear a new drug infusion device, the control device connects (for example, through Bluetooth connection) the health monitoring device, and obtains health monitoring data.

[0041] S604: The user wears an unexpired drug infusion device, and the control device wakes up the new drug infusion device through NFC and performs device verification, and then connects (for example, through Bluetooth connection) and activates the new drug infusion device.

[0042] S605: After the new drug infusion device is activated and connected successfully, the control device transmits (for example, through Bluetooth transmission) the information of the health monitoring device being used to the new drug infusion device.

[0043] S606: The new drug infusion device connects (for example, through Bluetooth connection) the health monitoring device and obtains health monitoring data.

[0044] S607: The user uses the control device (for example, through Bluetooth) to complete the control and use of the new drug infusion device and the health monitoring device, and obtains infusion device data and health monitoring information. The whole connection establishment after the two-way authentication mechanism is the same as before. At this point, the drug infusion device replacement is completed. FIG. 14 is a control device reconnection flowchart provided by the present application, including the following steps:

[0045] S701: The user normally uses the control device to connect the drug infusion device and the health monitoring device.

[0046] S702: When the control device is away from the drug infusion device and the health monitoring device, the control device will be disconnected with the drug infusion device (e.g., Bluetooth connection).

[0047] S703: After the drug infusion device detects the disconnection with the control device, it will enable the internal control algorithm to run independently of the control device; the drug infusion device remains connected with the health monitoring device (e.g., Bluetooth connection) to continuously support the drug infusion process.

[0048] S704: After the drug infusion device is disconnected with the control device, it will continue to send broadcast data packets (e.g., Bluetooth broadcast data packets) so that the control device can detect the drug infusion device when it is close.

[0049] S705: When the control device is close to the drug infusion device and the health monitoring device, the control device scans the broadcast data packet (for example, the Bluetooth broadcast data packet) of the drug infusion device, and actively connects with the drug infusion device through a connection (for example, a Bluetooth connection) to obtain infusion device data and health monitoring data again after completing bidirectional authentication. At this time, the control device can automatically restore to the normal connection use state when it is away from and close to the device. The health monitoring system provided in the application forms a health monitoring system by connecting the control device, the drug infusion device, and the health monitoring device, and the control device is responsible for the scheduling work of the whole system. The security of the whole system, the authentication between devices, and the encrypted transmission mechanism. When the drug infusion device or the health monitoring device expires, the control device can automatically discover and complete the activation use of the devices or devices that have not expired, and keep the communication link unchanged. When the effective connection range of the control device, the drug infusion device, and the health monitoring device changes, the control device can automatically discover and complete the Bluetooth connection of the devices, and keep the communication link unchanged. The control device has algorithm priority, intelligent calculation, and guidance for the normal operation of the drug infusion device. The drug infusion device has the receiving, analyzing, processing, and guidance ability of health monitoring data. FIG. 15 is a drug infusion device provided by the application. The drug infusion device can be a first drug infusion device 13, a second drug infusion device 16, a third drug infusion device, etc. As shown in FIG. 15, it includes a processor 1001, a communication interface 1002, a memory 1003, and a communication bus 1004. The processor 1001, the communication interface 1002, and the memory 1003 communicate with each other through the communication bus 1004. The memory 1003 stores a computer program. When the program is executed by the processor 1001, the processor 1001 executes any of the above method steps. The communication bus mentioned in the above electronic device can be a peripheral component interconnect (PCI) bus or an extended industry standard architecture (EISA) bus. The communication bus can be divided into an address bus, a data bus, and a control bus. For convenience of representation, only one thick line is shown in the figure, but it does not mean that there is only one bus or one type of bus. The communication interface 1002 is used for communication between the above electronic device and other devices.The memory can include a random access memory (RAM) and can also include a non-volatile memory (NVM), such as at least one disk memory. Optionally, the memory can also be at least one storage device located remotely from the aforementioned processor. The aforementioned processor can be a general purpose processor, including a central processing unit, a network processor (NP), etc. and can also be a digital signal processor (DSP), an application-specific integrated circuit, a field programmable gate array or other programmable logic device, discrete gate or transistor logic, discrete hardware components, etc. FIG. 16 is a health monitoring device provided by the present application, which can be the first health monitoring device 12, the second monitoring device, the third monitoring device, etc. As shown in FIG. 16, the health monitoring device includes a processor 1101, a communication interface 1102, a memory 1103 and a communication bus 1104, wherein the processor 1101, the communication interface 1102 and the memory 1103 complete communication with each other through the communication bus 1104. The memory 1103 stores a computer program, and when the program is executed by the processor 1101, the processor 1101 executes any one of the above method steps. FIG. 17 is a control device provided by the present application, as shown in FIG. 17, the control device includes a processor 1201, a communication interface 1202, a memory 1203 and a communication bus 1204, wherein the processor 1201, the communication interface 1202 and the memory 1203 complete communication with each other through the communication bus 1204. The memory 1203 stores a computer program, and when the program is executed by the processor 1201, the processor 1201 executes any one of the above method steps. The present application also provides a computer storage readable storage medium, which stores a computer program executable by an electronic device, and when the program runs on the electronic device, the electronic device executes the above any one method step. Although the preferred embodiments of the present application have been described, those skilled in the art can make additional changes and modifications to the embodiments once they know the basic inventive concept. Therefore, the appended claims are intended to be interpreted as including the preferred embodiments and all changes and modifications falling within the scope of the present application. Obviously, those skilled in the art can make various modifications and variations to the present application without departing from the spirit and scope of the present application.Thus, it is intended that this application cover all modifications and variations of this application provided they come within the scope of the appended claims and their equivalents.

Claims

CLAIM 1. A health monitoring system, characterized by, The system comprises: a control device, a first health monitoring device and a first drug infusion device; the control device is used for being connected with the first health monitoring device and the first drug infusion device for bidirectional authentication respectively, and activating the first health monitoring device and the first drug infusion device; the first health monitoring device is used for broadcasting a first data packet, and carrying first identification information of itself in the first data packet; the control device is used for receiving the first data packet, obtaining the first identification information carried therein, and sending the first identification information to the first drug infusion device; the first drug infusion device is used for scanning connectable health monitoring devices, matching to the first health monitoring device according to the first identification information, and establishing a connection with the first health monitoring device; the first health monitoring device is used for obtaining target health monitoring data of a first user, and sending the target health monitoring data to the first drug infusion device; the first drug infusion device is used for sending the target health monitoring data to the control device, receiving drug infusion indexes corresponding to the target health monitoring data sent by the control device, and infusing drugs to the first user according to the drug infusion indexes.

2. The system of claim 1, wherein, The first health monitoring device is used for obtaining target health monitoring data of a first user, and sending the target health monitoring data to the first drug infusion device after encryption by a first shared key; the first drug infusion device is used for decrypting the target health monitoring data by using the first shared key, and encrypting the decrypted data by using a second shared key, sending the data encrypted by using the second shared key to the control device, and receiving the data encrypted by using a third shared key and corresponding to the target health monitoring data sent by the control device, decrypting the data by using the third shared key, and obtaining the drug infusion indexes, and infusing drugs to the first user according to the drug infusion indexes. 37 The system further comprises a server; the control device is used for waking up the first drug infusion device by using a near field communication (NFC) technology; the first drug infusion device is used for broadcasting a second data packet, and carrying second identification information of itself in the second data packet; the control device is used for receiving the second data packet, obtaining the second identification information carried therein, and sending the second identification information to the server for verification; the server is used for returning first authentication information to the control device after verification.

3. The system of claim 1, wherein ​ The control device is configured to be connected with the first drug infusion device and perform bidirectional authentication using the first authentication information, generate a fourth shared key after the authentication is successful, and activate the first drug infusion device. The first drug infusion device is configured to generate the fourth shared key and return an activation success notification.

4. The system of claim 3, wherein, The control device is configured to wake up the first health monitoring device through NFC, and the first health monitoring device is configured to broadcast a third data packet carrying a first identification information of the first health monitoring device, the control device is configured to receive the third data packet, acquire the first identification information carried in the third data packet, and send the first identification information to the server for verification, and the server is configured to return second authentication information to the control device after the verification is passed. The first health monitoring device is configured to generate the fifth shared key and return an activation success notification.

5. The system of claim 4, wherein, The control device is configured to randomly generate third authentication information, encrypt the third authentication information using the fifth shared key, and send the encrypted third authentication information to the first health monitoring device. 38 The first health monitoring device is configured to decrypt the received encrypted information using the fifth shared key, and acquire the third authentication information. The control device is configured to encrypt the first identification information and the third authentication information using the fourth shared key, and send the encrypted information to the first drug infusion device. The first drug infusion device is configured to decrypt the received encrypted information using the fourth shared key, and acquire the third authentication information and the first identification information. The first health monitoring device is configured to broadcast a fourth data packet carrying the first identification information of the first health monitoring device. The first drug infusion device is configured to scan connectable health monitoring devices, match the first health monitoring device according to the first identification information, and establish a connection with the first health monitoring device. The first drug infusion device is configured to perform bidirectional authentication with the first health monitoring device using the third authentication information, generate a sixth shared key after the authentication is successful, and return first status information indicating that the first health monitoring device is successfully bound to the control device.

6. The system of claim 1, wherein The system further comprises: a second health monitoring device; the first drug infusion device is further used for disconnecting the first health monitoring device when it is identified that the first health monitoring device is out of date, and sending second state information that the first drug infusion device is disconnected with the first health monitoring device and third state information that the first health monitoring device is out of date to the control device; the control device is further used for waking up the second health monitoring device through NFC after receiving the second state information and the third state information; the second health monitoring device is used for broadcasting a fifth data packet, and the fifth data packet carries third identification information of the second health monitoring device; the control device is used for receiving the fifth data packet, obtaining the third identification information carried in the fifth data packet, and connecting and activating the second health monitoring device through bidirectional authentication, and sending the third identification information to the first drug infusion device; the control device is used for randomly generating fourth authentication information and sending the fourth authentication information to the second health device and the first drug infusion device through encryption; the first drug infusion device is used for scanning connectable health monitoring devices, matching the second health monitoring device according to the third identification information, and connecting the second health monitoring device through bidirectional authentication according to the fourth authentication information. The system further comprises: a second drug infusion device; the control device is further used for connecting a third health monitoring device activated last time, and obtaining health monitoring data collected by the third health monitoring device when it is identified that the first drug infusion device is out of date and the second drug infusion device is not detected; the control device is further used for waking up, bidirectionally authenticating and activating the second drug infusion device through NFC when the second drug infusion device is detected, and sending fourth identification information of the third health monitoring device to the second drug infusion device; the control device is used for randomly generating fifth authentication information and sending the fifth authentication information to the third health monitoring device and the second drug infusion device through encryption; the second drug infusion device is used for scanning connectable health monitoring devices, matching the third health monitoring device according to the fourth identification information, and connecting the third health monitoring device through bidirectional authentication according to the fifth authentication information.

7. The system of claim 6, wherein The control device is further used for disconnecting the third drug infusion device when it is detected that the control device is away from the third drug infusion device and the fourth health monitoring device in a connected state; the third drug infusion device is used for receiving health monitoring data sent by the fourth health monitoring device after it is detected that the third drug infusion device is disconnected with the control device, and determining a drug infusion index corresponding to the health monitoring data, and infusing drug to the first user according to the drug infusion index.

8. The system according to any of claims 1-7, characterized in that ​ 9. The system of claim 8, wherein, After the third drug infusion device is disconnected from the control device, the third drug infusion device is further configured to broadcast a sixth data packet, and the sixth data packet carries fifth identification information of the third drug infusion device; the control device is further configured to scan connectable drug infusion devices, match the third drug infusion device according to the fifth identification information, and establish a connection with the third drug infusion device; and the third drug infusion device is configured to, after detecting that the connection with the control device is established and bidirectional authentication is successful, receive health monitoring data sent by the fourth health monitoring device, send the health monitoring data to the control device, receive drug infusion indicators corresponding to the health monitoring data sent by the control device, and infuse drugs into the first user according to the drug infusion indicators.

10. A health monitoring method, characterized by, The method applied to the first drug infusion device comprises: the first drug infusion device scans connectable health monitoring devices, matches the first health monitoring device according to first identification information of the first health monitoring device, and establishes a connection with the first health monitoring device; wherein the first identification information is obtained by the control device receiving a first data packet broadcast by the first health monitoring device and sending the first identification information carried in the first data packet to the first drug infusion device; the first drug infusion device receives target health monitoring data of the first user sent by the first health monitoring device, sends the target health monitoring data to the control device, receives drug infusion indicators corresponding to the target health monitoring data sent by the control device, and infuses drugs into the first user according to the drug infusion indicators.

11. A health monitoring method, characterized by, The method applied to the first health monitoring device comprises: the first health monitoring device broadcasts a first data packet, and the first data packet carries first identification information of the first health monitoring device; the control device receives the first data packet, obtains the first identification information carried in the first data packet, and sends the first identification information to the first drug infusion device; the first drug infusion device scans connectable health monitoring devices, matches the first health monitoring device according to the first identification information, and establishes a connection with the first health monitoring device; the first drug infusion device obtains target health monitoring data of the first user, and sends the target health monitoring data to the first drug infusion device; the first drug infusion device sends the target health monitoring data to the control device, receives drug infusion indicators corresponding to the target health monitoring data sent by the control device, and infuses drugs into the first user according to the drug infusion indicators. The method applied to the control device comprises: the control device is bidirectionally authenticated with the first health monitoring device and the first drug infusion device, respectively, and activates the first health monitoring device and the first drug infusion device.

12. A health monitoring method, characterized by, ​ Receive the first data packet broadcast by the first health monitoring device, obtain the first identification information carried therein, and send the first identification information to the first drug infusion device; the first drug infusion device scans the connectable health monitoring device, matches the first health monitoring device according to the first identification information, and establishes a connection with the first health monitoring device; receive the target health monitoring data of the first user sent by the first drug infusion device, wherein the target health monitoring data is sent by the first health monitoring device to the first drug infusion device; determine the drug infusion index corresponding to the target health monitoring data, and send the drug infusion index to the first drug infusion device, and the first drug infusion device infuses the drug to the first user according to the drug infusion index.

13. A drug infusion device, characterized by, The device comprises a processor, a communication interface, a memory and a communication bus, wherein the processor, the communication interface and the memory complete mutual communication through the communication bus; the memory is used for storing a computer program; the processor is used for executing the program stored on the memory to realize the method steps of claim 10.

14. A health monitoring device, characterized by, The device comprises a processor, a communication interface, a memory and a communication bus, wherein the processor, the communication interface and the memory complete mutual communication through the communication bus; the memory is used for storing a computer program; 42 The processor is used for executing the program stored on the memory to realize the method steps of claim 11.

15. A control device, characterized by, The device comprises a processor, a communication interface, a memory and a communication bus, wherein the processor, the communication interface and the memory complete mutual communication through the communication bus; the memory is used for storing a computer program; the processor is used for executing the program stored on the memory to realize the method steps of claim 12. 43

Images